MoonLake Immunotherapeutics MLTX Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's comprehensive income (loss), net of tax, attributable to parent?
- MoonLake Immunotherapeutics (MLTX) reported comprehensive income (loss), net of tax, attributable to parent of -$69.99M in Q1 2026.
- How has MoonLake Immunotherapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- MoonLake Immunotherapeutics's comprehensive income (loss), net of tax, attributable to parent decreased by 64.4% year-over-year, from -$42.56M to -$69.99M.
- What is the long-term trend for MoonLake Immunotherapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Over 3 years (2022 to 2025), MoonLake Immunotherapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a 61.9% compound annual growth rate (CAGR), from -$54.6M to -$231.73M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from all sources, combining both net income and other comprehensive income items. It serves as the ultimate measure of the company's financial growth or contraction during the reporting period. By including all gains and losses, it offers a holistic view of the company's total economic value movement.